IDEXX beats Q1 earnings and revenue forecasts, raises 2021 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that surpassed market forecasts and raised its 2021 outlook to reflect expectations for higher organic revenue growth and better operating margins.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing said that first-quarter revenue was $778 million, an increase of 24% on a reported basis and 21% higher organically over a year earlier. That exceeded the consensus forecast of analysts polled by Zacks Investment Research by 5.87%. Read more

Related Posts

UNE receives $10.8 million to establish new Center for Cell Signaling Research

The University of New England has received a five-year, $10.8 million award from the National Institutes of Health to support an...

18 January 2024

Jackson Lab opens $4.5M on-site child care center in Bar Harbor

Anewly constructed child care center on the Jackson Laboratory’s Bar Harbor campus is seen as an important draw for employees that also...

17 January 2024

From med tech to skin care: Top Gun names 41 startups to 2024 lineup

Out of 57 companies that applied to Maine’s 2024 Top Gun business accelerator program, 41 have been accepted and will receive help...

16 January 2024